Non-coverage is simply a PBM cost control/reporting issue. Warfarin a lot cheaper and PBMs can report to their business customers that their pharm costs have been effectively managed.
Clearly does not take into effect cost of warfarin monitoring, etc.
Nothing to do with marketing, simply a dollar issue.
Market Data 
Markets 
AI
